Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laparoscopic TAP Block for TEP Inguinal Hernia Repair
NCT02632136Phase 3Unknown
- Sponsor
- Mayo University Hospital
- Start
- Nov 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Mayo University Hospital. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02632136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02632136.